【作者】 张惠敏; 高京宏; 李树法; 安丽华;
【Author】 ZHANG Hui-min1,GAO Jing-hong2,LI Shu-fa3,AN Li-hua4(1.Teaching Center for Composite Medical Courses,Beijing University of Chinese Medicine,Beijing 100029,China;2.Department of Traditional Chinese Medicine,Beijing General Corps Hospital of Armed Police,Beijing 100027,China;3.Department of Endocrine,the First People’s Hospital of Guiyang City,Guizhou Guiyang 550002,China;4.Community Health Service Center of Guangning Street of Shijingshan District in Beijing,Beijing 100041,China)
【机构】 北京中医药大学医学综合课程教学中心; 武警北京市总队医院中医科; 贵阳市第一人民医院内分泌科; 北京石景山区广宁街道社区卫生服务中心;
【摘要】 药物的疗效和安全性通过结局指标的报告来体现,因此恰当地选择并报告结局指标是临床研究中应该重视的关键环节。目前中药治疗糖尿病足随机对照试验的文献在结局指标的选择和报告方面存在以下问题:滥用综合性指标评价结局;结局评价指标模糊不清;结局评价指标不分主次;结局评价标准不统一;缺少对不良事件的报告。因此,应明确定义主次结局指标,并且说明测量方法;对主要和次要结局指标分别进行报告,避免采用综合性结局指标;采用相对效应指标和绝对效应指标相结合的报告方法;报告药物不良事件。 更多还原
【Abstract】 The efficacy and safety of drugs are reflected by clinical outcomes,so correctly selecting and reporting the clinical outcomes is the key in clinical research.Recently,some problems exist in literatures associated with selecting and reporting clinical outcomes of randomized controlled clinical trials on diabetic foot ulcer by Chinese herbal medicine,that is,misuse of synthetic outcomes,vague outcomes,not distinguishing primary outcomes from secondary ones,a unified evaluating standard of outcome... 更多还原
【基金】 首都医学发展科研基金(2009_3094)
中华医学之家:http://www.xinxi85.com
投稿信箱:zhyxzj85@163.com
联系电话:029--85327298 主编QQ:693891972